MediWound (MDWD) Shares Outstanding (Weighted Average) (2013 - 2025)
MediWound (MDWD) recorded quarterly Shares Outstanding (Weighted Average) of $258000.0 in Q4 2025, down 97.66% quarter-over-quarter from $11.0 million in Q3 2025, and down 97.61% on a YoY basis from $10.8 million in Q4 2024.
MediWound (MDWD) Shares Outstanding (Weighted Average) (2013 - 2025) Analysis & Trends
MediWound's Shares Outstanding (Weighted Average) history runs 13 years deep, the most recent figure standing at $258000.0 for Q4 2025.
- In Q4 2025, Shares Outstanding (Weighted Average) fell 97.61% year-over-year to $258000.0; the TTM figure through Dec 2025 stood at $258000.0 (down 97.61% YoY), while the FY2025 annual figure was $258000.0, down 97.61% from the prior year.
- Shares Outstanding (Weighted Average) was $258000.0 for Q4 2025 at MediWound, down from $11.0 million in the prior quarter.
- In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $239.0 million in Q2 2025 to a low of $320.0 in Q2 2023.
- Historically, Shares Outstanding (Weighted Average) has averaged $31.3 million across 5 years, with a median of $10.7 million in 2024.
- The sharpest annual moves came in 2023 and 2025: Shares Outstanding (Weighted Average) sank 100.0% in 2023, then jumped 13815738.15% in 2025.
- A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $3.9 million in 2021, then gained by 28.13% to $5.0 million in 2022, then jumped by 80.73% to $9.0 million in 2023, then grew by 19.72% to $10.8 million in 2024, then plunged by 97.61% to $258000.0 in 2025.
- The last three Shares Outstanding (Weighted Average) figures came in at $258000.0 (Q4 2025), $11.0 million (Q3 2025), and $239.0 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Weighted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | 185,491.37 Bn |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | 400.00 Bn |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | 4,489.46 Bn |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 100.00 Bn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | 118.76 Bn |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | 417.01 Bn |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | 68.88 Bn |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 254.10 Mn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | 928.40 Mn |
| 10 | MediWound | 3.70 Mn | 3.70 Mn | 278,000.00 | 258,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 258,000.00 |
| Sep 30, 2025 | 11.02 Mn |
| Jun 30, 2025 | 239.01 Mn |
| Mar 31, 2025 | 10.80 Mn |
| Dec 31, 2024 | 10.79 Mn |
| Sep 30, 2024 | 10.51 Mn |
| Jun 30, 2024 | 1,730.00 |
| Mar 31, 2024 | 9.23 Mn |
| Dec 31, 2023 | 9.01 Mn |
| Sep 30, 2023 | 9.22 Mn |
| Jun 30, 2023 | 320.00 |
| Mar 31, 2023 | 8.39 Mn |
| Dec 31, 2022 | 4.99 Mn |
| Sep 30, 2022 | 33.48 Mn |
| Jun 30, 2022 | 154.12 Mn |
| Mar 31, 2022 | 28.73 Mn |
| Dec 31, 2021 | 3.89 Mn |
| Sep 30, 2021 | 27.25 Mn |
| Jun 30, 2021 | 27.24 Mn |
| Mar 31, 2021 | 27.24 Mn |